Pharmaceuticals

Peptide Therapeutics Market Outlook 2026–2030 Driven By Growth Factors And Projections

May 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Changes In Market Value Are Expected For The Peptide Therapeutics Market Over The 2026–2030 Period?

The peptide therapeutics market size has experienced rapid expansion in recent years. It is forecast to increase from $49.21 billion in 2025 to $54.62 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.0%. This historical growth can be attributed to the early adoption of peptide drugs, the evolution of peptide synthesis techniques, a rising incidence of chronic and rare diseases, advancements in pharmacology and biochemistry, and the proliferation of contract research organizations.

The peptide therapeutics market is projected to experience substantial expansion in the coming years, reaching a valuation of $83.57 billion by 2030, driven by a compound annual growth rate (CAGR) of 11.2%. This anticipated growth during the forecast period is fueled by several factors, including the emergence of personalized medicine, increased capital directed towards peptide-based treatments, the incorporation of AI into drug discovery processes, the broadening of biologics manufacturing capabilities, and the expansion of healthcare solution markets in developing regions. Key trends identified for the forecast period encompass the creation of targeted peptide drugs, advancements in peptide drug delivery methods, the development of multi-functional peptide therapeutic agents, improved natural peptide extraction and synthesis techniques, and the use of combination therapies incorporating peptides.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7216&type=smp

What Key Drivers Are Fueling The Growth Of The Peptide Therapeutics Market?

The rising incidence of chronic diseases is projected to fuel the expansion of the peptide therapeutics market. These conditions are enduring illnesses, often resistant to cure, though at times manageable and treatable. Factors contributing to their surge include greater consumption of tobacco products, inadequate nutrition, lack of physical activity, excessive alcohol intake, among others. Peptide therapeutics play a role in both preventing and managing particular chronic diseases. As an illustration, data from January 2023, provided by the US-based National Library of Medicine, indicates that by 2050, the population in the US aged 50 and older suffering from at least one chronic condition is set to grow by 99.5%, reaching 142.66 million individuals. Consequently, the expanding prevalence of chronic diseases is anticipated to boost the peptide therapeutics market throughout the forecast period.

How Is The Peptide Therapeutics Market Categorized Across Its Segment Groups?

The peptide therapeutics market covered in this report is segmented –

1) By Type: Generic, Branded

2) By Route of Administration: Parenteral, Mucosal, Oral, Transdermal

3) By Application: Cancer, Cardiovascular Diseases, Central Nervous Systems, Metabolic Disorders, Infections, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders, Acromegaly, Other Applications

Subsegments:

1) By Generic: Generic Peptide Drugs, Biosimilars

2) By Branded: Innovative Peptide Drugs, Patent-Protected Peptides

What Trends Are Affecting The Direction Of The Peptide Therapeutics Market?

Major companies operating in the peptide therapeutics market are focusing on implementing advanced solutions, such as the cell culture process, to achieve a competitive advantage. The cell culture process involves cultivating cells outside their natural environment under controlled conditions, by isolating cells of interest from living tissue and subsequently maintaining them. For example, in June 2023, Evonik Industries AG, a German-based specialty chemicals company, launched cQrex KC. This cQrex KC is a next-generation peptide for biopharma applications, specifically designed for the cell culture process used in the manufacture of biological drugs. It allows cell culture process developers to optimize cystine supply and improve cell culture productivity, thereby supporting the development of vaccines, viral vectors, and cell therapies.

Which Firms Are Influencing Competition In The Peptide Therapeutics Market?

Major companies operating in the peptide therapeutics market are Pfizer Inc., Jhonson & Jhonson, Abbvie Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk AS, Teva Pharmaceuticals Industries Ltd., Bachem Holding AG, PolyPeptide Laboratories BV, Arcus Biosciences Inc., Pepscan Therapeutics, Peptech Inc., Peptide Logic Inc., SELLAS Life Sciences Group, Ever Neuro Pharma GmbH, Zealand Pharma AG, PepGen Inc., Pepticom S.A., Peptide Technologies Corporation, SynPeptide Inc., Peptimmune Inc., Merck & Co Inc.

Get The Full Peptide Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

Which Geographic Region Dominates The Peptide Therapeutics Market?

North America was the largest region in the peptide therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Peptide Therapeutics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

Browse Through More Reports Similar to the Global Peptide Therapeutics Market 2026, By The Business Research Company

Peptide Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

Peptide Synthesis Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptide-synthesis-global-market-report

Peptide Based Metabolic Disorders Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptide-based-metabolic-disorders-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795